Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

OBJECTIVE: Increases in serum calcitonin, a tumor marker for medullary thyroid carcinoma (MTC), have been associated with glucagon-like peptide 1 receptor agonist use in some preclinical studies. We report calcitonin changes in exenatide-treated and placebo-administered participants and MTC incidenc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Care
Auteurs principaux: Bethel, M. Angelyn, Patel, Rishi A., Thompson, Vivian P., Merrill, Peter, Reed, Shelby D., Li, Yanhong, Ahmadi, Sara, Katona, Brian G., Gustavson, Stephanie M., Ohman, Peter, Iqbal, Nayyar, Gagel, Robert F., Hernandez, Adrian F., Buse, John B., Holman, Rury R.
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2019
Sujets:
Emerging Therapies: Drugs and Regimens
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973544/
https://ncbi.nlm.nih.gov/pubmed/31010875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2028
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires